An inside look at the games, deals, and incentives that often result in higher costs, delays in care, or denials of treatment for patients in the American medical system.
The pharmaceutical world is rife with rebates and side deals—all designed to elbow ahead of the competition. But apparently the price of convenience comes at a steep mark-up.
Lawrence Schlachter has seen medicine from inside the operating room and the courtroom. Lots of doctors care about patient safety, he says. "They're just afraid to come out."
The Justice Department claimed patient safety celebrity Dr. Chuck Denham solicited payments from a drug company to win a prestigious National Quality Forum endorsement for its product.
Kickback allegations against its former editor prompted the Journal of Patient Safety to review his writings and adopt new standards for disclosing commercial conflicts of interest.
A conversation with Jeanine Thomas, patient advocate, active member of ProPublica's Patient Harm Facebook Community, and founder and president of the MRSA Survivors Network.
Top patient-safety experts call on Congress to step in and, among other steps, give the Centers for Disease Control and Prevention wider responsibility for measuring medical mistakes.
A study by Medicare’s inspector general of skilled nursing facilities says nearly 22,000 patients were injured and more than 1,500 died in a single month—a higher rate of medical errors than hospitals.